Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1041705

Identification of prodigious and under- privileged structural features for RG7834 analogs as Hepatitis B virus expression inhibitor


Masand, Vijay H.; El-Sayed, Nahed; Rastija, Vesna; Rathore, Mithilesh; Karnaš, Maja
Identification of prodigious and under- privileged structural features for RG7834 analogs as Hepatitis B virus expression inhibitor // Medicinal chemistry research, 28 (2019), 12; 2270-2278 doi:10.1007/s00044-019-02455-w (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1041705 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Identification of prodigious and under- privileged structural features for RG7834 analogs as Hepatitis B virus expression inhibitor

Autori
Masand, Vijay H. ; El-Sayed, Nahed ; Rastija, Vesna ; Rathore, Mithilesh ; Karnaš, Maja

Izvornik
Medicinal chemistry research (1054-2523) 28 (2019), 12; 2270-2278

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
RG7834 analogs ; hepatitis B virus ; dihydroquinolizinone ; QSAR ; pharmacophore modeling

Sažetak
In the present work, QSAR (quantitative structure−activity relationship) analysis has been executed for RG7834 analogs. RG7834 is a first-in-class selective and orally available dihydroquinolizinone (DHQ)-based small molecule Hepatitis B virus expression inhibitor. OECD’s guidelines have been followed for developing multiple QSAR models for Hepatitis B virus expression inhibitory activity of 73 RG7834 analogs. The present multiple QSAR models are not only easily interpretable but possess high external predictive ability, as well. These are effective in the recognition of many privileged and underprivileged molecular descriptors, which could be very valuable for the use of these models by the experts and nonexperts of QSAR in future optimizations. The models satisfy threshold values for many fitting, internal and external validation parameters, such as R2 = 0.83, Q2 = 0.80, CCCext = 0.88, etc., thereby demonstrating good external predictive ability of the models. The multiple QSAR and pharmacophoric models successfully identified a good number of important positively and negatively related structural features of RG7834 analogs that govern their Hepatitis B virus expression inhibitory activity. The results could be very beneficial to synthetic/medicinal chemists for future alterations of RG7834 analogs as better drug candidates.

Izvorni jezik
Engleski

Znanstvena područja
Kemija, Farmacija



POVEZANOST RADA


Ustanove
Fakultet agrobiotehničkih znanosti Osijek

Profili:

Avatar Url Vesna Rastija (autor)

Avatar Url Maja Karnaš (autor)

Citiraj ovu publikaciju

Masand, Vijay H.; El-Sayed, Nahed; Rastija, Vesna; Rathore, Mithilesh; Karnaš, Maja
Identification of prodigious and under- privileged structural features for RG7834 analogs as Hepatitis B virus expression inhibitor // Medicinal chemistry research, 28 (2019), 12; 2270-2278 doi:10.1007/s00044-019-02455-w (međunarodna recenzija, članak, znanstveni)
Masand, V., El-Sayed, N., Rastija, V., Rathore, M. & Karnaš, M. (2019) Identification of prodigious and under- privileged structural features for RG7834 analogs as Hepatitis B virus expression inhibitor. Medicinal chemistry research, 28 (12), 2270-2278 doi:10.1007/s00044-019-02455-w.
@article{article, year = {2019}, pages = {2270-2278}, DOI = {10.1007/s00044-019-02455-w}, keywords = {RG7834 analogs, hepatitis B virus, dihydroquinolizinone, QSAR, pharmacophore modeling}, journal = {Medicinal chemistry research}, doi = {10.1007/s00044-019-02455-w}, volume = {28}, number = {12}, issn = {1054-2523}, title = {Identification of prodigious and under- privileged structural features for RG7834 analogs as Hepatitis B virus expression inhibitor}, keyword = {RG7834 analogs, hepatitis B virus, dihydroquinolizinone, QSAR, pharmacophore modeling} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus


Citati





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font